Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Breast Cancer

Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation

Bone Marrow Transplantation volume 26, pages 947–953 (2000)Cite this article

Abstract

To determine the outcomes of women with isolated loco-regional recurrence (LRR) of breast cancer treated with high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) following conventional therapy, we conducted a retrospective review of 58 patients from five institutions treated between 1990 and 1998. Forty-five patients (78%) had ⩾2 poor prognostic factors (PPF) (defined as disease-free interval preceding LRR ⩽2 years, hormone receptor negative/refractory disease, and incomplete resection). At median follow-up of 14.2 (0.5–72) months, 36 patients (62%) developed progressive disease. Disease progression usually occurred at local (27 patients) vs distant (nine patients) sites. Median time to disease progression following ASCT was 6.1 (1.3–31.4) months. At last follow-up, 23 patients (40%) had expired (all due to disease progression), and 13 (22%) were alive with, and 22 (38%) without progressive disease. By Kaplan–Meier analysis, the estimated median PFS and OS was 20.3 and 29.2 months, respectively. In a multivariate model, complete remission at time of HDCT and estrogen-receptor positive disease were predictive of significantly longer PFS and OS. The survival of this cohort was similar to previous reports of those treated with conventional therapy alone, and to those with distant metastases treated with HDCT. Frequent progression locally, suggests that strategies to improve local disease control are needed. Bone Marrow Transplantation (2000) 26, 947–953.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Andry G, Suciu S, Vico P et al. Locoregional recurrences after 649 modified radical mastectomies: incidence and significance Eur J Surg Oncol 1989 15: 476–485

    CAS  PubMed  Google Scholar 

  2. Strender LE, Wallgren A, Arndt J et al. Adjuvant radiotherapy in operable breast cancer: correlation between dose in internal mammary nodes and prognosis Int J Radiat Oncol Biol Phys 1981 7: 1319–1325

    Article  CAS  Google Scholar 

  3. Lythgoe JP, Palmer MK . Manchester regional breast study: five and ten year results Br J Surg 1982 69: 693–696

    Article  CAS  Google Scholar 

  4. Fisher B, Wolmark N, Redmond C et al. Findings from NSABP protocol no. B-04: comparison of radical mastectomy with alternative treatments. II The clinical and biologic significance of medial-central breast cancers Cancer 1981 48: 1863–1872

    Article  CAS  Google Scholar 

  5. Overgaard M, Hansen PS, Overgaard J et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy New Engl J Med 1997 337: 949–955

    Article  CAS  Google Scholar 

  6. Ragaz J, Stewart MJ, Le N et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer New Engl J Med 1997 337: 956–962

    Article  CAS  Google Scholar 

  7. Recht A, Gray R, Davidson NE et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the eastern cooperative oncology group J Clin Oncol 1999 17: 1689–1700

    Article  CAS  Google Scholar 

  8. Halverson KJ, Perez CA, Kuske RR et al. Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis Int J Rad Oncol Biol Phys 1991 23: 285–291

    Article  Google Scholar 

  9. Willner J, Kiricuta IC, Kolbl Oliver et al. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis Int J Radiat Oncol Biol Phys 1997 37: 853–863

    Article  CAS  Google Scholar 

  10. Kamby C, Sengelov L . Patterns of dissemination and survival following isolated locoregional recurrence of breast cancer Breast Cancer Res Treat 1997 45: 181–192

    Article  CAS  Google Scholar 

  11. Schwaibold F, Fowble BL, Solin LJ et al. The results of radiation therapy for isolated local regional recurrence after mastectomy Int J Radiat Oncol Biol Phys 1991 21: 299–310

    Article  CAS  Google Scholar 

  12. Aberizk WJ, Silver B, Henderson IC et al. The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy Cancer 1986 58: 1214–1218

    Article  CAS  Google Scholar 

  13. Patanaphan V, Salazar OM, Poussin-Rosillo H et al. Prognosticators in recurrent breast cancer Cancer 1984 54: 228–234

    Article  CAS  Google Scholar 

  14. Toonkel LM, Fix I, Jacobson LH et al. The significance of local recurrence of carcinoma of the breast Int J Radiat Oncol Biol Phys 1981 9: 33–39

    Article  Google Scholar 

  15. Magno L, Bignardi M, Micheletti E et al. Analysis of prognostic factors in patients with isolated chest wall recurrence of breast cancer Cancer 1987 60: 240–244

    Article  CAS  Google Scholar 

  16. Probstfeld MR, O'Connell TX . Treatment of locally recurrent breast carcinoma Arch Surg 1989 124: 1127–1130

    Article  CAS  Google Scholar 

  17. Chen KK, Montague ED, Oswald MJ . Results of irradiation in the treatment of locoregional breast cancer recurrence Cancer 1985 56: 1269–1273

    Article  CAS  Google Scholar 

  18. Chu FCH, Lin FJ, Kim JH et al. Locally recurrent carcinoma of the breast. Results of radiation therapy Cancer 1976 37: 2677–2681

    Article  CAS  Google Scholar 

  19. Bedwinek JM, Lee J, Fineberg B et al. Prognostic indicators in patients with isolated loco-regional recurrence of breast cancer Cancer 1981 47: 2232–2235

    Article  CAS  Google Scholar 

  20. Bedwinek JM, Fineberg B, Lee J et al. Analysis of failures following local treatment of isolated local-regional recurrence of breast cancer Int J Radiat Oncol Biol Phys 1981 7: 581–585

    Article  CAS  Google Scholar 

  21. Borner M, Bacchi M, Goldhirsch A et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation J Clin Oncol 1994 12: 2071–2077

    Article  CAS  Google Scholar 

  22. Janjan NA, McNeese MD, Buzdar AU et al. Management of locoregional recurrent breast cancer Cancer 1986 58: 1552–1556

    Article  CAS  Google Scholar 

  23. Halverson K, Perez C, Kuske RR et al. Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy Am J Clin Oncol 1992 15: 93–101

    Article  CAS  Google Scholar 

  24. Buzdar AU, Blumenschein GR, Smith TL et al. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED0) J Surg Oncol 1979 12: 27–40

    Article  CAS  Google Scholar 

  25. Danoff B, Coia L . Locally recurrent breast carcinoma: the effect of adjuvant chemotherapy on prognosis Radiology 1983 147: 849–852

    Article  CAS  Google Scholar 

  26. Recht A, Silen W, Schnitt SJ et al. Time course of local recurrence following conservation surgery and radiotherapy for early stage breast cancer Int J Radiat Oncol Biol Phys 1988 15: 255–261

    Article  CAS  Google Scholar 

  27. Clark RM, Wilkinson RH, Miceli PN et al. Breast cancer: experiences with conservation therapy Am J Clin Oncol 1987 10: 461–468

    Article  CAS  Google Scholar 

  28. Fortin A, Larochelle M, Laverdiere J et al. Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy J Clin Oncol 1999 17: 101–109

    Article  CAS  Google Scholar 

  29. Fowble B, Solin LJ, Schultz DJ et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis and pathologic findings from mastectomy specimens with implications for treatment Int J Radiat Oncol Biol Phys 1990 19: 833–842

    Article  CAS  Google Scholar 

  30. Recht A, Schnitt SJ, Connolly JL et al. Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast cancer Int J Radiat Oncol Biol Phys 1989 16: 3–9

    Article  CAS  Google Scholar 

  31. Kurtz JM, Amalric R, Brandone H et al. Local recurrence after breast-conserving surgery and radiotherapy: frequency, time course and prognosis Cancer 1989 63: 1912–1917

    Article  CAS  Google Scholar 

  32. Haffty B, Reiss M, Beinfield M et al. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse J Clin Oncol 1996 14: 52–57

    Article  CAS  Google Scholar 

  33. Gage I, Schnitt S, Recht A et al. Skin recurrences after breast conserving therapy for early stage breast cancer J Clin Oncol 1998 16: 480–486

    Article  CAS  Google Scholar 

  34. Kouides PA, Abboud CN, Frediani KE et al. The infusion of mobilized peripheral blood stem cells alone after myeloablative therapy can accelerate hematopoietic recovery as rapidly as mobilized PBSCs with autologous bone marrow Blood 1993 82: (Suppl. 1) 289a (Abstr.)

    Google Scholar 

  35. Antman KH, Rowlings PA, Vaughan WP et al. High dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America J Clin Oncol 1997 15: 1870–1879

    Article  CAS  Google Scholar 

  36. Bezwoda WR, Seymour L, Dansey RD . High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial J Clin Oncol 1995 13: 2483–2489

    Article  CAS  Google Scholar 

  37. Stadtmauer EA, O'Neill A, Goldstein LJ et al. Phase III randomized trial of high-dose chemotherapy and stem cell support shows no difference in overall survival or severe toxicity compared to maintenance chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil for women with metastatic breast cancer who are responding to conventional induction chemotherapy: the ‘Philadelphia’ intergroup study (PBT-1) Proc Am Soc Clin Oncol 1999 18: 1a (Abstr.)

    Google Scholar 

  38. Carter DL, Marks LB, Bean JM et al. Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescue J Clin Oncol 1999 17: 887–893

    Article  CAS  Google Scholar 

  39. Rowlings PA, Williams SF, Antman KH et al. Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancer JAMA 1999 282: 1335–1343

    Article  CAS  Google Scholar 

  40. Rizzieri DA, Vredenburgh JJ, Jones R et al. Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support J Clin Oncol 1999 17: 3064–3074

    Article  CAS  Google Scholar 

  41. Ayash LJ, Wheeler C, Fairclough D et al. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer J Clin Oncol 1995 13: 2043–2049

    Article  CAS  Google Scholar 

  42. Dunphy FR, Spitzer G, Rossiter Fornoff JE et al. Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support Cancer 1994 73: 2157–2167

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Bone Marrow Transplantation and Stem Cell Biology, Washington University School of Medicine, St Louis, MO, USA

    R Vij, J DiPersio, R Brown, K Trinkaus, LT Goodnough, H Khoury & D Adkins

  2. Division of Hematology and Oncology, University of Rochester Med Center, Rochester, NY, USA

    C Abboud & J Ponnuri

  3. Division of Bone Marrow Transplantation, Georgetown University Medical Center, Washington, DC, USA

    KR Meehan

  4. Carolinas Med Center, Charlotte, NC, USA

    G Frenette

  5. Division of Hematology, University of Texas Health Sciences Center, San Antonio, TX, USA

    C Freytes

Authors
  1. R Vij
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J DiPersio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K Trinkaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C Abboud
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. KR Meehan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G Frenette
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C Freytes
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. LT Goodnough
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H Khoury
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J Ponnuri
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. D Adkins
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vij, R., DiPersio, J., Brown, R. et al. Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation. Bone Marrow Transplant 26, 947–953 (2000). https://doi.org/10.1038/sj.bmt.1702657

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702657

Keywords

Search

Advanced search

Quick links